TreeWAS – Variant ID: rs7581969

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
I84.9 Unspecified haemorrhoids without complication	0.000	0.986	0.014
I84.6 Residual haemorrhoidal skin tags	0.000	0.987	0.013
I84 Haemorrhoids	0.000	0.987	0.013
I84.2 Internal haemorrhoids without complication	0.000	0.989	0.011
I84.1 Internal haemorrhoids with other complications	0.000	0.989	0.011
I84.5 External haemorrhoids without complication	0.000	0.990	0.010
I84.0 Internal thrombosed haemorrhoids	0.000	0.990	0.009
I84.4 External haemorrhoids with other complications	0.000	0.990	0.009
I84.3 External thrombosed haemorrhoids	0.000	0.991	0.009
I84.8 Unspecified haemorrhoids with other complications	0.000	0.991	0.009
I84.7 Unspecified thrombosed haemorrhoids	0.000	0.992	0.008
Z91.0 Personal history of allergy, other than to drugs and biological substances	0.005	0.995	0.000
G56.0 Carpal tunnel syndrome	0.000	0.995	0.005
Y43.3 Other antineoplastic drugs	0.004	0.996	0.000
Z91.6 Personal history of other physical trauma	0.004	0.996	0.000
R20.2 Paraesthesia of skin	0.000	0.996	0.004
M13.99 Arthritis, unspecified (Site unspecified)	0.004	0.996	0.000
M35.3 Polymyalgia rheumatica	0.004	0.996	0.000
Z91 Personal history of risk-factors, not elsewhere classified	0.004	0.996	0.000
R20 Disturbances of skin sensation	0.000	0.997	0.003
Y43 Primarily systemic agents	0.003	0.997	0.000
M35 Other systemic involvement of connective tissue	0.003	0.997	0.000
R21 Rash and other nonspecific skin eruption	0.000	0.997	0.003
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.003	0.997	0.000
Z91.5 Personal history of self-harm	0.003	0.997	0.000
Z91.8 Personal history of other specified risk-factors, not elsewhere classified	0.003	0.997	0.000
Z91.7 Personal history of female genital mutilation	0.003	0.997	0.000
Z91.4 Personal history of psychological trauma, not elsewhere classified	0.003	0.997	0.000
Z91.3 Personal history of unhealthy sleep-wake schedule	0.003	0.997	0.000
Z91.2 Personal history of poor personal hygiene	0.003	0.997	0.000
M35.0 Sicca syndrome [Sjogren]	0.003	0.997	0.000
N50.8 Other specified disorders of male genital organs	0.003	0.997	0.000
N35.9 Urethral stricture, unspecified	0.003	0.997	0.000
R20.8 Other and unspecified disturbances of skin sensation	0.000	0.997	0.003
O63 Long labour	0.003	0.997	0.000
O63.0 Prolonged first stage (of labour)	0.003	0.997	0.000
C85.1 B-cell lymphoma, unspecified	0.003	0.997	0.000
M22.4 Chondromalacia patellae	0.003	0.997	0.000
Y43.9 Primarily systemic agent, unspecified	0.002	0.997	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.002	0.997	0.000
Y43.6 Enzymes, not elsewhere classified	0.002	0.997	0.000
Y43.5 Acidifying and alkalising agents	0.002	0.997	0.000
Y43.4 Immunosuppressive agents	0.002	0.997	0.000
Y43.2 Antineoplastic natural products	0.002	0.997	0.000
Y43.1 Antineoplastic antimetabolites	0.002	0.997	0.000
Y43.0 Antiallergic and antiemetic drugs	0.002	0.997	0.000
O60-O75 Complications of labour and delivery	0.003	0.997	0.000
R20.3 Hyperaesthesia	0.000	0.997	0.002
R20.1 Hypoaesthesia of skin	0.000	0.997	0.002
R20.0 Anaesthesia of skin	0.000	0.997	0.002
M35.9 Systemic involvement of connective tissue, unspecified	0.002	0.997	0.000
M35.8 Other specified systemic involvement of connective tissue	0.002	0.997	0.000
M35.7 Hypermobility syndrome	0.002	0.997	0.000
M35.6 Relapsing panniculitis [Weber-Christian]	0.002	0.997	0.000
M35.5 Multifocal fibrosclerosis	0.002	0.997	0.000
M35.4 Diffuse (eosinophilic) fasciitis	0.002	0.997	0.000
M35.2 Behcet's disease	0.002	0.997	0.000
M35.1 Other overlap syndromes	0.002	0.997	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.003	0.997	0.000
O68 Labour and delivery complicated by foetal stress [distress]	0.003	0.997	0.000
M22 Disorders of patella	0.002	0.997	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.002	0.997	0.000
O68.1 Labour and delivery complicated by meconium in amniotic fluid	0.002	0.997	0.000
B95.4 Other streptococcus as the cause of diseases classified to other chapters	0.002	0.998	0.000
M13.9 Arthritis, unspecified	0.002	0.998	0.000
R20-R23 Symptoms and signs involving the skin and subcutaneous tissue	0.000	0.998	0.002
C67.9 Bladder, unspecified	0.002	0.998	0.000
O73 Retained placenta and membranes, without haemorrhage	0.002	0.998	0.000
Y42.5 Other oestrogens and progestogens	0.002	0.998	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.002	0.998	0.000
M20-M25 Other joint disorders	0.002	0.998	0.000
O63.1 Prolonged second stage (of labour)	0.002	0.998	0.000
O70.1 Second degree perineal laceration during delivery	0.002	0.998	0.000
O70 Perineal laceration during delivery	0.002	0.998	0.000
E78.5 Hyperlipidaemia, unspecified	0.002	0.998	0.000
O64 Obstructed labour due to malposition and malpresentation of foetus	0.002	0.998	0.000
O68.0 Labour and delivery complicated by foetal heart rate anomaly	0.002	0.998	0.000
Y42.7 Androgens and anabolic congeners	0.002	0.998	0.000
M25 Other joint disorders, not elsewhere classified	0.002	0.998	0.000
O66 Other obstructed labour	0.002	0.998	0.000
M13.93 Arthritis, unspecified (Forearm)	0.002	0.998	0.000
O73.0 Retained placenta, without haemorrhage	0.002	0.998	0.000
S82.80 Fractures of other parts of lower leg (closed)	0.000	0.998	0.002
O63.9 Long labour, unspecified	0.002	0.998	0.000
Z91.1 Personal history of noncompliance with medical treatment and regimen	0.002	0.998	0.000
O34.2 Maternal care due to uterine scar from previous surgery	0.002	0.998	0.000
O63.2 Delayed delivery of second twin, triplet, etc.	0.002	0.998	0.000
O70.2 Third degree perineal laceration during delivery	0.002	0.998	0.000
Y40 Systemic antibiotics	0.002	0.998	0.000
M13.95 Arthritis, unspecified (Pelvic region and thigh)	0.002	0.998	0.000
K80.1 Calculus of gallbladder with other cholecystitis	0.002	0.998	0.000
O75 Other complications of labour and delivery, not elsewhere classified	0.002	0.998	0.000
O74 Complications of anaesthesia during labour and delivery	0.002	0.998	0.000
O71 Other obstetric trauma	0.002	0.998	0.000
O67 Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified	0.002	0.998	0.000
O65 Obstructed labour due to maternal pelvic abnormality	0.002	0.998	0.000
O62 Abnormalities of forces of labour	0.002	0.998	0.000
O61 Failed induction of labour	0.002	0.998	0.000
O60 Preterm delivery	0.002	0.998	0.000
M35.99 Systemic involvement of connective tissue, unspecified, Site unspecified	0.002	0.998	0.000
O64.1 Obstructed labour due to breech presentation	0.002	0.998	0.000
M13.96 Arthritis, unspecified (Lower leg)	0.002	0.998	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.002	0.998	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.002	0.998	0.000
C85.0 Lymphosarcoma	0.002	0.998	0.000
M25.5 Pain in joint	0.002	0.998	0.000
M31 Other necrotising vasculopathies	0.002	0.998	0.000
M25.56 Pain in joint (Lower leg)	0.002	0.998	0.000
O68.9 Labour and delivery complicated by foetal stress, unspecified	0.002	0.998	0.000
Y40.0 Penicillins	0.002	0.998	0.000
M24 Other specific joint derangements	0.002	0.998	0.000
B95 Streptococcus and staphylococcus as the cause of diseases classified to other chapters	0.002	0.998	0.000
G56 Mononeuropathies of upper limb	0.000	0.998	0.002
O66.5 Failed application of vacuum extractor and forceps, unspecified	0.002	0.998	0.000
O68.3 Labour and delivery complicated by biochemical evidence of foetal stress	0.002	0.998	0.000
M13.98 Arthritis, unspecified (Other)	0.002	0.998	0.000
M22.1 Recurrent subluxation of patella	0.002	0.998	0.000
M22.9 Disorder of patella, unspecified	0.002	0.998	0.000
M22.8 Other disorders of patella	0.002	0.998	0.000
M22.3 Other derangements of patella	0.002	0.998	0.000
M22.2 Patellofemoral disorders	0.002	0.998	0.000
M22.0 Recurrent dislocation of patella	0.002	0.998	0.000
M25.4 Effusion of joint	0.002	0.998	0.000
Y42.9 Other and unspecified hormone antagonists	0.002	0.998	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.002	0.998	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.002	0.998	0.000
Y42.4 Oral contraceptives	0.002	0.998	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.002	0.998	0.000
Y42.2 Antithyroid drugs	0.002	0.998	0.000
Y42.1 Thyroid hormones and substitutes	0.002	0.998	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.002	0.998	0.000
O69 Labour and delivery complicated by umbilical cord complications	0.002	0.998	0.000
M13.92 Arthritis, unspecified (Upper arm)	0.002	0.998	0.000
R23 Other skin changes	0.000	0.998	0.002
M25.59 Pain in joint (Site unspecified)	0.002	0.998	0.000
O73.1 Retained portions of placenta and membranes, without haemorrhage	0.002	0.998	0.000
Y59 Other and unspecified vaccines and biological substances	0.002	0.998	0.000
Y58 Bacterial vaccines	0.002	0.998	0.000
Y57 Other and unspecified drugs and medicaments	0.002	0.998	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.002	0.998	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.002	0.998	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.002	0.998	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
Y52 Agents primarily affecting the cardiovascular system	0.002	0.998	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.002	0.998	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
Y48 Anaesthetics and therapeutic gases	0.002	0.998	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.002	0.998	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.002	0.998	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.002	0.998	0.000
M36 Systemic disorders of connective tissue in diseases classified elsewhere	0.002	0.998	0.000
M34 Systemic sclerosis	0.002	0.998	0.000
M33 Dermatopolymyositis	0.002	0.998	0.000
M32 Systemic lupus erythematosus	0.002	0.998	0.000
M30 Polyarteritis nodosa and related conditions	0.002	0.998	0.000
M21 Other acquired deformities of limbs	0.002	0.998	0.000
M13.94 Arthritis, unspecified (Hand)	0.002	0.998	0.000
M25.57 Pain in joint (Ankle and foot)	0.002	0.998	0.000
B95.5 Unspecified streptococcus as the cause of diseases classified to other chapters	0.002	0.998	0.000
O70.9 Perineal laceration during delivery, unspecified	0.002	0.998	0.000
O70.3 Fourth degree perineal laceration during delivery	0.002	0.998	0.000
O64.9 Obstructed labour due to malposition and malpresentation, unspecified	0.002	0.998	0.000
O64.8 Obstructed labour due to other malposition and malpresentation	0.002	0.998	0.000
O64.5 Obstructed labour due to compound presentation	0.002	0.998	0.000
O64.4 Obstructed labour due to shoulder presentation	0.002	0.998	0.000
O64.3 Obstructed labour due to brow presentation	0.002	0.998	0.000
O64.2 Obstructed labour due to face presentation	0.002	0.998	0.000
O68.8 Labour and delivery complicated by other evidence of foetal stress	0.002	0.998	0.000
C67 Malignant neoplasm of bladder	0.002	0.998	0.000
M23 Internal derangement of knee	0.002	0.998	0.000
Y44 Agents primarily affecting blood constituents	0.002	0.998	0.000
C67.3 Anterior wall of bladder	0.002	0.998	0.000
M31.6 Other giant cell arteritis	0.002	0.998	0.000
O64.0 Obstructed labour due to incomplete rotation of foetal head	0.002	0.998	0.000
M24.1 Other articular cartilage disorders	0.002	0.998	0.000
M25.9 Joint disorder, unspecified	0.002	0.998	0.000
M25.8 Other specified joint disorders	0.002	0.998	0.000
M25.6 Stiffness of joint, not elsewhere classified	0.002	0.998	0.000
M25.3 Other instability of joint	0.002	0.998	0.000
M25.2 Flail joint	0.002	0.998	0.000
M25.1 Fistula of joint	0.002	0.998	0.000
M25.0 Haemarthrosis	0.002	0.998	0.000
O66.9 Obstructed labour, unspecified	0.002	0.998	0.000
O66.8 Other specified obstructed labour	0.002	0.998	0.000
O66.4 Failed trial of labour, unspecified	0.002	0.998	0.000
O66.3 Obstructed labour due to other abnormalities of foetus	0.002	0.998	0.000
O66.2 Obstructed labour due to unusually large foetus	0.002	0.998	0.000
O66.1 Obstructed labour due to locked twins	0.002	0.998	0.000
O66.0 Obstructed labour due to shoulder dystocia	0.002	0.998	0.000
M25.7 Osteophyte	0.002	0.998	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.002	0.998	0.000
O34 Maternal care for known or suspected abnormality of pelvic organs	0.002	0.998	0.000
O72 Postpartum haemorrhage	0.002	0.998	0.000
M25.47 Effusion of joint (Ankle and foot)	0.002	0.998	0.000
B95.3 Streptococcus pneumoniae as the cause of diseases classified to other chapters	0.002	0.998	0.000
O75.7 Vaginal delivery following previous Caesarean section	0.002	0.998	0.000
Y40.9 Systemic antibiotic, unspecified	0.002	0.998	0.000
Y40.8 Other systemic antibiotics	0.002	0.998	0.000
Y40.7 Antifungal antibiotics, systemically used	0.002	0.998	0.000
Y40.6 Rifamycins	0.002	0.998	0.000
Y40.5 Aminoglycosides	0.002	0.998	0.000
Y40.4 Tetracyclines	0.002	0.998	0.000
Y40.3 Macrolides	0.002	0.998	0.000
Y40.2 Chloramphenicol group	0.002	0.998	0.000
Y40.1 Cefalosporins and other -lactam antibiotics	0.002	0.998	0.000
B95.6 Staphylococcus aureus as the cause of diseases classified to other chapters	0.002	0.998	0.000
B95.1 Streptococcus, group B, as the cause of diseases classified to other chapters	0.002	0.998	0.000
C67.2 Lateral wall of bladder	0.002	0.998	0.000
O60.3 Preterm delivery without spontaneous labour	0.002	0.998	0.000
O60.2 Preterm spontaneous labour with term delivery	0.002	0.998	0.000
O60.1 Preterm spontaneous labour with preterm delivery	0.002	0.998	0.000
O60.0 Preterm labour without delivery	0.002	0.998	0.000
O61.9 Failed induction of labour, unspecified	0.002	0.998	0.000
O61.8 Other failed induction of labour	0.002	0.998	0.000
O61.1 Failed instrumental induction of labour	0.002	0.998	0.000
O61.0 Failed medical induction of labour	0.002	0.998	0.000
O62.9 Abnormality of forces of labour, unspecified	0.002	0.998	0.000
O62.8 Other abnormalities of forces of labour	0.002	0.998	0.000
O62.4 Hypertonic, incoordinate and prolonged uterine contractions	0.002	0.998	0.000
O62.3 Precipitate labour	0.002	0.998	0.000
O62.2 Other uterine inertia	0.002	0.998	0.000
O62.1 Secondary uterine inertia	0.002	0.998	0.000
O62.0 Primary inadequate contractions	0.002	0.998	0.000
O65.9 Obstructed labour due to maternal pelvic abnormality, unspecified	0.002	0.998	0.000
O65.8 Obstructed labour due to other maternal pelvic abnormalities	0.002	0.998	0.000
O65.5 Obstructed labour due to abnormality of maternal pelvic organs	0.002	0.998	0.000
O65.4 Obstructed labour due to foetopelvic disproportion, unspecified	0.002	0.998	0.000
O65.3 Obstructed labour due to pelvic outlet and midcavity contraction	0.002	0.998	0.000
O65.2 Obstructed labour due to pelvic inlet contraction	0.002	0.998	0.000
O65.1 Obstructed labour due to generally contracted pelvis	0.002	0.998	0.000
O65.0 Obstructed labour due to deformed pelvis	0.002	0.998	0.000
O67.9 Intrapartum haemorrhage, unspecified	0.002	0.998	0.000
O67.8 Other intrapartum haemorrhage	0.002	0.998	0.000
O67.0 Intrapartum haemorrhage with coagulation defect	0.002	0.998	0.000
O71.9 Obstetric trauma, unspecified	0.002	0.998	0.000
O71.8 Other specified obstetric trauma	0.002	0.998	0.000
O71.7 Obstetric haematoma of pelvis	0.002	0.998	0.000
O71.6 Obstetric damage to pelvic joints and ligaments	0.002	0.998	0.000
O71.5 Other obstetric injury to pelvic organs	0.002	0.998	0.000
O71.4 Obstetric high vaginal laceration alone	0.002	0.998	0.000
O71.3 Obstetric laceration of cervix	0.002	0.998	0.000
O71.2 Postpartum inversion of uterus	0.002	0.998	0.000
O71.1 Rupture of uterus during labour	0.002	0.998	0.000
O71.0 Rupture of uterus before onset of labour	0.002	0.998	0.000
O74.9 Complication of anaesthesia during labour and delivery, unspecified	0.002	0.998	0.000
O74.8 Other complications of anaesthesia during labour and delivery	0.002	0.998	0.000
O74.7 Failed or difficult intubation during labour and delivery	0.002	0.998	0.000
O74.6 Other complications of spinal and epidural anaesthesia during labour and delivery	0.002	0.998	0.000
O74.5 Spinal and epidural anaesthesia-induced headache during labour and delivery	0.002	0.998	0.000
O74.4 Toxic reaction to local anaesthesia during labour and delivery	0.002	0.998	0.000
O74.3 Central nervous system complications of anaesthesia during labour and delivery	0.002	0.998	0.000
O74.2 Cardiac complications of anaesthesia during labour and delivery	0.002	0.998	0.000
O74.1 Other pulmonary complications of anaesthesia during labour and delivery	0.002	0.998	0.000
O74.0 Aspiration pneumonitis due to anaesthesia during labour and delivery	0.002	0.998	0.000
O75.9 Complication of labour and delivery, unspecified	0.002	0.998	0.000
O75.8 Other specified complications of labour and delivery	0.002	0.998	0.000
O75.5 Delayed delivery after artificial rupture of membranes	0.002	0.998	0.000
O75.4 Other complications of obstetric surgery and procedures	0.002	0.998	0.000
O75.3 Other infection during labour	0.002	0.998	0.000
O75.2 Pyrexia during labour, not elsewhere classified	0.002	0.998	0.000
O75.1 Shock during or following labour and delivery	0.002	0.998	0.000
O75.0 Maternal distress during labour and delivery	0.002	0.998	0.000
M25.58 Pain in joint (Other)	0.002	0.998	0.000
M25.54 Pain in joint (Hand)	0.002	0.998	0.000
M25.53 Pain in joint (Forearm)	0.002	0.998	0.000
M25.52 Pain in joint (Upper arm)	0.002	0.998	0.000
M31.9 Necrotising vasculopathy, unspecified	0.002	0.998	0.000
M31.8 Other specified necrotising vasculopathies	0.002	0.998	0.000
M31.7 Microscopic polyangiitis	0.002	0.998	0.000
M31.5 Giant cell arteritis with polymyalgia rheumatica	0.002	0.998	0.000
M31.4 Aortic arch syndrome [Takayasu]	0.002	0.998	0.000
M31.3 Wegener's granulomatosis	0.002	0.998	0.000
M31.2 Lethal midline granuloma	0.002	0.998	0.000
M31.1 Thrombotic microangiopathy	0.002	0.998	0.000
M31.0 Hypersensitivity angiitis	0.002	0.998	0.000
M24.16 Other articular cartilage disorders (Lower leg)	0.002	0.998	0.000
M25.76 Osteophyte (Lower leg)	0.002	0.998	0.000
M23.4 Loose body in knee	0.002	0.998	0.000
M24.9 Joint derangement, unspecified	0.002	0.998	0.000
M24.8 Other specific joint derangements, not elsewhere classified	0.002	0.998	0.000
M24.7 Protrusio acetabuli	0.002	0.998	0.000
M24.6 Ankylosis of joint	0.002	0.998	0.000
M24.5 Contracture of joint	0.002	0.998	0.000
M24.4 Recurrent dislocation and subluxation of joint	0.002	0.998	0.000
M24.3 Pathological dislocation and subluxation of joint, not elsewhere classified	0.002	0.998	0.000
M24.2 Disorder of ligament	0.002	0.998	0.000
M24.0 Loose body in joint	0.002	0.998	0.000
O68.2 Labour and delivery complicated by foetal heart rate anomaly with meconium in amniotic fluid	0.002	0.998	0.000
M25.78 Osteophyte (Other)	0.002	0.998	0.000
B95.2 Streptococcus, group D, as the cause of diseases classified to other chapters	0.002	0.998	0.000
B95.0 Streptococcus, group A, as the cause of diseases classified to other chapters	0.002	0.998	0.000
G56.9 Mononeuropathy of upper limb, unspecified	0.000	0.998	0.002
G56.8 Other mononeuropathies of upper limb	0.000	0.998	0.002
G56.4 Causalgia	0.000	0.998	0.002
G56.3 Lesion of radial nerve	0.000	0.998	0.002
G56.1 Other lesions of median nerve	0.000	0.998	0.002
M22.10 Recurrent subluxation of patella, unspecified knee	0.002	0.998	0.000
M25.49 Effusion of joint (Site unspecified)	0.002	0.998	0.000
M25.48 Effusion of joint (Other)	0.002	0.998	0.000
M25.45 Effusion of joint (Pelvic region and thigh)	0.002	0.998	0.000
M25.44 Effusion of joint (Hand)	0.002	0.998	0.000
M25.43 Effusion of joint (Forearm)	0.002	0.998	0.000
M25.42 Effusion of joint (Upper arm)	0.002	0.998	0.000
M25.41 Effusion of joint (Shoulder region)	0.002	0.998	0.000
M25.40 Effusion of joint (Multiple sites)	0.002	0.998	0.000
M13.91 Arthritis, unspecified (Shoulder region)	0.002	0.998	0.000
M25.46 Effusion of joint (Lower leg)	0.002	0.998	0.000
M25.51 Pain in joint (Shoulder region)	0.002	0.998	0.000
C67.4 Posterior wall of bladder	0.002	0.998	0.000
O69.9 Labour and delivery complicated by cord complication, unspecified	0.002	0.998	0.000
O69.8 Labour and delivery complicated by other cord complications	0.002	0.998	0.000
O69.5 Labour and delivery complicated by vascular lesion of cord	0.002	0.998	0.000
O69.4 Labour and delivery complicated by vasa praevia	0.002	0.998	0.000
O69.3 Labour and delivery complicated by short cord	0.002	0.998	0.000
O69.0 Labour and delivery complicated by prolapse of cord	0.002	0.998	0.000
O75.6 Delayed delivery after spontaneous or unspecified rupture of membranes	0.002	0.998	0.000
M23.8 Other internal derangements of knee	0.002	0.998	0.000
R23.8 Other and unspecified skin changes	0.000	0.998	0.001
R23.4 Changes in skin texture	0.000	0.998	0.001
R23.3 Spontaneous ecchymoses	0.000	0.998	0.001
R23.2 Flushing	0.000	0.998	0.001
R23.1 Pallor	0.000	0.998	0.001
R23.0 Cyanosis	0.000	0.998	0.001
M13.90 Arthritis, unspecified (Multiple sites)	0.002	0.998	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.001	0.998	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.001	0.998	0.000
Y41.5 Antiviral drugs	0.001	0.998	0.000
Y41.4 Anthelminthics	0.001	0.998	0.000
Y41.3 Other antiprotozoal drugs	0.001	0.998	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.001	0.998	0.000
Y41.1 Antimycobacterial drugs	0.001	0.998	0.000
Y41.0 Sulphonamides	0.001	0.998	0.000
Y46.8 Antispasticity drugs	0.001	0.998	0.000
Y46.7 Anti-Parkinsonism drugs	0.001	0.998	0.000
Y46.6 Other and unspecified antiepileptics	0.001	0.998	0.000
Y46.5 Valproic acid	0.001	0.998	0.000
Y46.4 Iminostilbenes	0.001	0.998	0.000
Y46.3 Deoxybarbiturates	0.001	0.998	0.000
Y46.2 Hydantoin derivatives	0.001	0.998	0.000
Y46.1 Oxazolidinediones	0.001	0.998	0.000
Y46.0 Succinimides	0.001	0.998	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.001	0.998	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.001	0.998	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.001	0.998	0.000
Y47.4 Bromine compounds	0.001	0.998	0.000
Y47.3 Paraldehyde	0.001	0.998	0.000
Y47.2 Chloral derivatives	0.001	0.998	0.000
Y47.1 Benzodiazepines	0.001	0.998	0.000
Y47.0 Barbiturates, not elsewhere classified	0.001	0.998	0.000
Y48.5 Therapeutic gases	0.001	0.998	0.000
Y48.4 Anaesthetic, unspecified	0.001	0.998	0.000
Y48.3 Local anaesthetics	0.001	0.998	0.000
Y48.2 Other and unspecified general anaesthetics	0.001	0.998	0.000
Y48.1 Parenteral anaesthetics	0.001	0.998	0.000
Y48.0 Inhaled anaesthetics	0.001	0.998	0.000
Y49.9 Psychotropic drug, unspecified	0.001	0.998	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.001	0.998	0.000
Y49.7 Psychostimulants with abuse potential	0.001	0.998	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.001	0.998	0.000
Y49.5 Other antipsychotics and neuroleptics	0.001	0.998	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.001	0.998	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.001	0.998	0.000
Y49.2 Other and unspecified antidepressants	0.001	0.998	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.001	0.998	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.001	0.998	0.000
Y50.9 Central nervous system stimulant, unspecified	0.001	0.998	0.000
Y50.8 Other central nervous system stimulants	0.001	0.998	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.001	0.998	0.000
Y50.1 Opioid receptor antagonists	0.001	0.998	0.000
Y50.0 Analeptics	0.001	0.998	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.001	0.998	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.001	0.998	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.001	0.998	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.001	0.998	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.001	0.998	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.001	0.998	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.001	0.998	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.001	0.998	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.001	0.998	0.000
Y51.0 Anticholinesterase agents	0.001	0.998	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.001	0.998	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.001	0.998	0.000
Y52.7 Peripheral vasodilators	0.001	0.998	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.001	0.998	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.001	0.998	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.001	0.998	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.001	0.998	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.001	0.998	0.000
Y52.1 Calcium-channel blockers	0.001	0.998	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.001	0.998	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.001	0.998	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.001	0.998	0.000
Y53.7 Emetics	0.001	0.998	0.000
Y53.6 Antidiarrhoeal drugs	0.001	0.998	0.000
Y53.5 Digestants	0.001	0.998	0.000
Y53.4 Other laxatives	0.001	0.998	0.000
Y53.3 Saline and osmotic laxatives	0.001	0.998	0.000
Y53.2 Stimulant laxatives	0.001	0.998	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.001	0.998	0.000
Y53.0 Histamine H2-receptor antagonists	0.001	0.998	0.000
Y54.9 Mineral salts, not elsewhere classified	0.001	0.998	0.000
Y54.8 Agents affecting uric acid metabolism	0.001	0.998	0.000
Y54.7 Agents affecting calcification	0.001	0.998	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.001	0.998	0.000
Y54.5 Other diuretics	0.001	0.998	0.000
Y54.4 Loop [high-ceiling] diuretics	0.001	0.998	0.000
Y54.3 Benzothiadiazine derivatives	0.001	0.998	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.001	0.998	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.001	0.998	0.000
Y54.0 Mineralocorticoids	0.001	0.998	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.001	0.998	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.001	0.998	0.000
Y55.5 Anticommon cold drugs	0.001	0.998	0.000
Y55.4 Expectorants	0.001	0.998	0.000
Y55.3 Antitussives	0.001	0.998	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.001	0.998	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.001	0.998	0.000
Y55.0 Oxytocic drugs	0.001	0.998	0.000
Y56.9 Topical agent, unspecified	0.001	0.998	0.000
Y56.8 Other topical agents	0.001	0.998	0.000
Y56.7 Dental drugs, topically applied	0.001	0.998	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.001	0.998	0.000
Y56.5 Ophthalmological drugs and preparations	0.001	0.998	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.001	0.998	0.000
Y56.3 Emollients, demulcents and protectants	0.001	0.998	0.000
Y56.2 Local astringents and local detergents	0.001	0.998	0.000
Y56.1 Antipruritics	0.001	0.998	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.001	0.998	0.000
Y57.9 Drug or medicament, unspecified	0.001	0.998	0.000
Y57.8 Other drugs and medicaments	0.001	0.998	0.000
Y57.7 Vitamins, not elsewhere classified	0.001	0.998	0.000
Y57.6 Other diagnostic agents	0.001	0.998	0.000
Y57.5 X-ray contrast media	0.001	0.998	0.000
Y57.4 Pharmaceutical excipients	0.001	0.998	0.000
Y57.3 Alcohol deterrents	0.001	0.998	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.001	0.998	0.000
Y57.1 Lipotropic drugs	0.001	0.998	0.000
Y57.0 Appetite depressants [anorectics]	0.001	0.998	0.000
Y58.9 Other and unspecified bacterial vaccines	0.001	0.998	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.001	0.998	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.001	0.998	0.000
Y58.5 Diphtheria vaccine	0.001	0.998	0.000
Y58.4 Tetanus vaccine	0.001	0.998	0.000
Y58.3 Plague vaccine	0.001	0.998	0.000
Y58.2 Cholera vaccine	0.001	0.998	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.001	0.998	0.000
Y58.0 BCG vaccine	0.001	0.998	0.000
Y59.9 Vaccine or biological substance, unspecified	0.001	0.998	0.000
Y59.8 Other specified vaccines and biological substances	0.001	0.998	0.000
Y59.3 Immunoglobulin	0.001	0.998	0.000
Y59.2 Protozoal vaccines	0.001	0.998	0.000
Y59.1 Rickettsial vaccines	0.001	0.998	0.000
Y59.0 Viral vaccines	0.001	0.998	0.000
K80.5 Calculus of bile duct without cholangitis or cholecystitis	0.002	0.998	0.000
M21.9 Acquired deformity of limb, unspecified	0.001	0.998	0.000
M21.8 Other specified acquired deformities of limbs	0.001	0.998	0.000
M21.7 Unequal limb length (acquired)	0.001	0.998	0.000
M21.6 Other acquired deformities of ankle and foot	0.001	0.998	0.000
M21.5 Acquired clawhand, clubhand, clawfoot and clubfoot	0.001	0.998	0.000
M21.4 Flat foot [pes planus] (acquired)	0.001	0.998	0.000
M21.3 Wrist or foot drop (acquired)	0.001	0.998	0.000
M21.2 Flexion deformity	0.001	0.998	0.000
M21.1 Varus deformity, not elsewhere classified	0.001	0.998	0.000
M21.0 Valgus deformity, not elsewhere classified	0.001	0.998	0.000
M30.8 Other conditions related to polyarteritis nodosa	0.001	0.998	0.000
M30.3 Mucocutaneous lymph node syndrome [Kawasaki]	0.001	0.998	0.000
M30.2 Juvenile polyarteritis	0.001	0.998	0.000
M30.1 Polyarteritis with lung involvement [Churg-Strauss]	0.001	0.998	0.000
M30.0 Polyarteritis nodosa	0.001	0.998	0.000
M32.9 Systemic lupus erythematosus, unspecified	0.001	0.998	0.000
M32.8 Other forms of systemic lupus erythematosus	0.001	0.998	0.000
M32.1 Systemic lupus erythematosus with organ or system involvement	0.001	0.998	0.000
M32.0 Drug-induced systemic lupus erythematosus	0.001	0.998	0.000
M33.9 Dermatopolymyositis, unspecified	0.001	0.998	0.000
M33.2 Polymyositis	0.001	0.998	0.000
M33.1 Other dermatomyositis	0.001	0.998	0.000
M33.0 Juvenile dermatomyositis	0.001	0.998	0.000
M34.9 Systemic sclerosis, unspecified	0.001	0.998	0.000
M34.8 Other forms of systemic sclerosis	0.001	0.998	0.000
M34.2 Systemic sclerosis induced by drugs and chemicals	0.001	0.998	0.000
M34.1 CR(E)ST syndrome	0.001	0.998	0.000
M34.0 Progressive systemic sclerosis	0.001	0.998	0.000
M36.8 Systemic disorders of connective tissue in other diseases classified elsewhere	0.001	0.998	0.000
M36.4 Arthropathy in hypersensitivity reactions classified elsewhere	0.001	0.998	0.000
M36.3 Arthropathy in other blood disorders	0.001	0.998	0.000
M36.2 Haemophilic arthropathy	0.001	0.998	0.000
M36.1 Arthropathy in neoplastic disease	0.001	0.998	0.000
M36.0 Dermato(poly)myositis in neoplastic disease	0.001	0.998	0.000
O69.2 Labour and delivery complicated by other cord entanglement	0.001	0.998	0.000
B95.8 Unspecified staphylococcus as the cause of diseases classified to other chapters	0.002	0.998	0.000
B95.7 Other staphylococcus as the cause of diseases classified to other chapters	0.002	0.998	0.000
C67.8 Overlapping lesion of bladder	0.002	0.998	0.000
C67.7 Urachus	0.002	0.998	0.000
C67.6 Ureteric orifice	0.002	0.998	0.000
C67.5 Bladder neck	0.002	0.998	0.000
C67.1 Dome of bladder	0.002	0.998	0.000
C67.0 Trigone of bladder	0.002	0.998	0.000
M23.9 Internal derangement of knee, unspecified	0.002	0.998	0.000
M23.6 Other spontaneous disruption of ligament(s) of knee	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations